SEC Filing Timeline
10-QNov 09, 2026
Quarterly report
8-KNov 09, 2026
Earnings release · Items 2.02,9.01
8-KOct 08, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
S-3Aug 31, 2026
Shelf registration
10-QAug 05, 2026
Quarterly report
8-KAug 05, 2026
Executive officer change · Items 2.02,5.02,9.01
8-KJun 18, 2026
Shareholder vote results · Items 5.07
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Material agreement · Items 1.01,8.01,9.01
8-KMay 26, 2026
Other material event · Items 8.01
424B5May 26, 2026
Prospectus / offering
8-KMay 26, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
Recent News (Finnhub)
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?
What Will Decide Vertex Stock Over The Next Six Months?
Editas Medicine Plans Human Trial After Gene Therapy Slashed LDL 90% in Primate Study
Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
Editas: Q3 Earnings Snapshot
Editas Medicine Announces Third Quarter 2026 Results and Business Updates
Editas Medicine Q3 EPS $(0.15) Beats $(0.18) Estimate, Sales $10.365M Beat $4.460M Estimate
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Lags Revenue Estimates